Lista de

vasculotropin receptor 2
22
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation" (2015) Ahmad, S.;Hewett, P.W.;Fujisawa, T. (...)Ahmed, A. Thrombosis and Haemostasis. 113(2):329-337
"Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation" (2015) Ahmad, S.;Hewett, P.W.;Fujisawa, T. (...)Ahmed, A. Thrombosis and Haemostasis. 113(2):329-337
"Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model" (2015) Di Pietro, M.;Parborell, F.;Irusta, G. (...)Abramovich, D. Endocrinology. 156(4):1453-1463
"Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome" (2014) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Journal of Steroid Biochemistry and Molecular Biology. 144(PART B):392-401
"Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome" (2014) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Journal of Steroid Biochemistry and Molecular Biology. 144(PART B):392-401
"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors" (2014) Croci, D.O.;Cerliani, J.P.;Dalotto-Moreno, T. (...)Rabinovich, G.A. Cell. 156(4):744-758
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia" (2013) Freitag, N.;Tirado-Gonzaĺez, I.;Barrientos, G. (...)Blois, S.M. Proceedings of the National Academy of Sciences of the United States of America. 110(28):11451-11456
"Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome" (2012) Abramovich, D.;Irusta, G.;Bas, D. (...)Tesone, M. Endocrinology. 153(7):3446-3456
"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479
"Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas" (2011) Luque, G.M.;Perez-Millán, M.I.;Ornstein, A.M. (...)Becu-Villalobos, D. Journal of Pharmacology and Experimental Therapeutics. 337(3):766-774
"Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model" (2008) Quintana, R.;Kopcow, L.;Marconi, G. (...)Paz, D.A. Fertility and Sterility. 90(4 SUPPL):1511-1516
"Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs" (2008) Parborell, F.; Irusta, G.; Celín, A.R.; Tesone, M. Molecular Reproduction and Development. 75(4):623-631